ETF DAILY NEWS

Q2 EPS Estimates for UroGen Pharma Raised by HC Wainwright

UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) – Investment analysts at HC Wainwright increased their Q2 2025 earnings per share (EPS) estimates for UroGen Pharma in a report issued on Thursday, May 22nd. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings per share of ($0.74) for the quarter, up from […]

May 27, 2025 - 06:26
 0
Q2 EPS Estimates for UroGen Pharma Raised by HC Wainwright
UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) – Investment analysts at HC Wainwright increased their Q2 2025 earnings per share (EPS) estimates for UroGen Pharma in a report issued on Thursday, May 22nd. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings per share of ($0.74) for the quarter, up from […]
Read More

Tags:

Previous Article

Zacks Research Has Negative Forecast for IDEX Q2 Earnings

Next Article

Zacks Research Increases Earnings Estimates for Imperial Oil

Related Posts

Roth Capital Has Pessimistic View of Powerfleet Q1 Earnings

Roth Capital Has Pessimistic View of Powerfleet Q1 Earn...

May 30, 2025  0

Molson Coors Beverage (NYSE:TAP) Price Target Cut to $59.00 by Analysts at UBS Group

Molson Coors Beverage (NYSE:TAP) Price Target Cut to $5...

May 12, 2025  0

Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE:PAC) Shares Acquired by Northern Trust Corp

Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE:...

May 16, 2025  0